MGX (Metagenomi) Total Stockholders Equity : $212.66 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Total Stockholders Equity?

Metagenomi's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $212.66 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Metagenomi's Book Value per Share for the quarter that ended in Mar. 2025 was $5.69. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Metagenomi's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.21.

Metagenomi Total Stockholders Equity Historical Data

The historical data trend for Metagenomi's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Total Stockholders Equity Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

-32.54

-74.43

-135.58

234.86

Metagenomi Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial							275.63	269.42	255.77	234.86	212.66

Metagenomi (NAS:MGX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Metagenomi's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(212.658	-	0)	/	37.382
	=	5.69

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Metagenomi's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.603	+	38.834)	/	212.658
	=	0.21

Metagenomi Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Metagenomi's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, 7th Floor, Emeryville, CA, USA, 94608

Website

https://metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.